Abstract
The development of time-resolved fluoroimmunoassays (TRFIAs) was driven by the need to eliminate the use of radioactive isotopes in immunoassays and to develop automatic and ultrasensitive immunoassays. The use of time-resolved fluorescence became possible through the development of chelates that bound lanthanides with high affinity and could be coupled to proteins. This was combined with methods to dissociate the primary chelate together with the formation of a highly fluorescent new complex. The advantages of this technology are most efficiently used in sandwich assays using two antibodies, a solid phase antibody capturing the antigen and a detector antibody labeled with a lanthanide complex. This method facilitated a 10–100-fold lower detection limit in combination with an assay range covering 5–6 orders of magnitude. These advantages have facilitated elucidation of new biological phenomena and development of unique clinical applications. These have proved to be especially valuable for the determination of protein hormones and tumor markers. This review describes the clinical application of TRFIA.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ACT:
-
α1-Antichymotrypsin
- Aio!:
-
All-in-one
- BPH:
-
Benign prostatic hyperplasia
- cpm:
-
Counts per minute
- DELFIAs:
-
Dissociation-enhanced lanthanide fluoroimmunoassays
- Dy:
-
Dysprosium
- Eu:
-
Europium
- fPSA:
-
Free PSA
- FSH:
-
Follicle-stimulating hormone
- GH:
-
Growth hormone
- hCG:
-
Human chorionic gonadotropin
- hCGβ:
-
β Subunit of human chorionic gonadotropin
- hK2:
-
Human kallikrein 2
- IEMA:
-
Immuno-enzymometric assays
- IFMA:
-
Immunofluorometric assay
- Ig:
-
Immunoglobulin
- IRMA:
-
Immunoradiometric assay
- KLK:
-
Kallikrein-related peptidase
- LH:
-
Luteinizing hormone
- MAb:
-
Monoclonal antibody
- PCR:
-
Polymerase chain reaction
- PSA:
-
Prostate-specific antigen
- PSA-ACT:
-
Complex between PSA and ACT
- RIA:
-
Radioimmunoassay
- Sm:
-
Samarium
- Tb:
-
Terbium
- tPSA:
-
Total PSA (sum of free and complexed PSA)
- TRFIA:
-
Time-resolved fluoroimmunoassay, time-resolved fluorometric assay
- TR-FRET:
-
Time-resolved fluorescence resonance energy transfer
References
Soini E, Kojola H (1983) Time-resolved fluorometer for lanthanide chelates – a new generation of nonisotopic immunoassays. Clin Chem 29:65–68
Ekins RP (1998) Ligand assays: from electrophoresis to miniaturized microarrays. Clin Chem 44:2015–2030
Lovgren T, Hemmila I, Pettersson K, Eskola JU, Bertoft E (1984) Determination of hormones by time-resolved fluoroimmunoassay. Talanta 31:909–916
Hemmila I (1985) Fluoroimmunoassays and immunofluorometric assays. Clin Chem 31:359–370
Soini E, Hemmila I, Dahlen P (1990) Time-resolved fluorescence in biospecific assays. Ann Biol Clin (Paris) 48:567–571
Hemmila I, Dakubu S, Mukkala VM, Siitari H, Lovgren T (1984) Europium as a label in time-resolved immunofluorometric assays. Anal Biochem 137:335–343
Xu Y, Li Q (2007) Multiple fluorescent labeling of silica nanoparticles with lanthanide chelates for highly sensitive time-resolved immunofluorometric assays. Clin Chem 53:1503–1510
Pettersson K, Alfthan H, Stenman UH, Turpeinen U, Suonpaa M, Soderholm J et al (1993) Simultaneous assay of alpha-fetoprotein and free beta subunit of human chorionic gonadotropin by dual-label time-resolved immunofluorometric assay. Clin Chem 39:2084–2089
Mitrunen K, Pettersson K, Piironen T, Bjork T, Lilja H, Lovgren T (1995) Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum. Clin Chem 41:1115–1120
Zhu L, Leinonen J, Zhang WM, Finne P, Stenman UH (2003) Dual-label immunoassay for simultaneous measurement of prostate-specific antigen (PSA)-alpha1-antichymotrypsin complex together with free or total PSA. Clin Chem 49:97–103
Meurman OH, Hemmila IA, Lovgren TN, Halonen PE (1982) Time-resolved fluoroimmunoassay: a new test for rubella antibodies. J Clin Microbiol 16:920–925
Tanner P, Stenman U-H, Seppälä M, Schröder J (1982) Sensitive and specific RIA for human chorionic gonadotropin (hCG) using monoclonal antibodies. Protides Biol Fluids 29:843–846
Dechaud H, Bador R, Claustrat F, Desuzinges C (1986) Laser-excited immunofluorometric assay of prolactin, with use of antibodies coupled to lanthanide-labeled diethylenetriaminepentaacetic acid. Clin Chem 32:1323–1327
Tarkkinen P, Palenius T, Lovgren T (2002) Ultrarapid, ultrasensitive one-step kinetic immunoassay for C-reactive protein (CRP) in whole blood samples: measurement of the entire CRP concentration range with a single sample dilution. Clin Chem 48:269–277
von Lode P, Rainaho J, Laiho MK, Punnonen K, Peltola O, Harjola VP, Pettersson K (2006) Sensitive and quantitative, 10-min immunofluorometric assay for d-dimer in whole blood. Thromb Res 118:573–585
von Lode P, Rainaho J, Pettersson K (2004) Quantitative, wide-range, 5-minute point-of-care immunoassay for total human chorionic gonadotropin in whole blood. Clin Chem 50:1026–1035
Khosravi MJ, Chan MA, Bellem AC, Diamandis EP (1988) A sensitive time-resolved immunofluorometric assay of ferritin in serum with monoclonal antibodies. Clin Chim Acta 175:267–275
Black MH, Grass CL, Leinonen J, Stenman UH, Diamandis EP (1999) Characterization of monoclonal antibodies for prostate-specific antigen and development of highly sensitive free prostate-specific antigen assays. Clin Chem 45:347–354
Diamandis EP (1988) Immunoassays with time-resolved fluorescence spectroscopy: principles and applications. Clin Biochem 21:139–150
Mathis G (1993) Rare earth cryptates and homogeneous fluoroimmunoassays with human sera. Clin Chem 39:1953–1959
Mathis G, Socquet F, Viguier M, Darbouret B (1997) Homogeneous immunoassays using rare earth cryptates and time resolved fluorescence: principles and specific advantages for tumor markers. Anticancer Res 17:3011–3014
Dahlen P, Hurskainen P, Lovgren T, Hyypia T (1988) Time-resolved fluorometry for the identification of viral DNA in clinical specimens. J Clin Microbiol 26:2434–2436
Dahlen P, Syvanen AC, Hurskainen P, Kwiatkowski M, Sund C, Ylikoski J et al (1987) Sensitive detection of genes by sandwich hybridization and time-resolved fluorometry. Mol Cell Probes 1:159–168
Nurmi J, Ylikoski A, Soukka T, Karp M, Lovgren T (2000) A new label technology for the detection of specific polymerase chain reaction products in a closed tube. Nucleic Acids Res 28:E28
Alfthan H (1986) Comparison of immunoradiometric and immunofluorometric assays for serum hCG. J Immunol Methods 88:239–244
Madersbacher S, Shu-Chen T, Schwarz S, Dirnhofer S, Wick G, Berger P (1993) Time-resolved immunofluorometry and other frequently used immunoassay types for follicle-stimulating hormone compared by using identical monoclonal antibodies. Clin Chem 39:1435–1439
Ferguson RA, Yu H, Kalyvas M, Zammit S, Diamandis EP (1996) Ultrasensitive detection of prostate-specific antigen by a time-resolved immunofluorometric assay and the immulite immunochemiluminescent third-generation assay: potential applications in prostate and breast cancers. Clin Chem 42:675–684
Robertson DM, Pruysers E, Stephenson T, Pettersson K, Morton S, McLachlan RI (2001) Sensitive LH and FSH assays for monitoring low serum levels in men undergoing steroidal contraception. Clin Endocrinol (Oxf) 55:331–339
Stenman UH (1997) Immunoassay standardisation. In: Price C, Newman D (eds) Principles and practice of immunoassay, 2nd edn. Macmillan, London, pp 245–268
Dunkel L, Alfthan H, Stenman UH, Tapanainen P, Perheentupa J (1990) Pulsatile secretion of LH and FSH in prepubertal and early pubertal boys revealed by ultrasensitive time-resolved immunofluorometric assays. Pediatr Res 27:215–219
Apter D, Cacciatore B, Alfthan H, Stenman UH (1989) Serum luteinizing hormone concentrations increase 100-fold in females from 7 years to adulthood, as measured by time-resolved immunofluorometric assay. J Clin Endocrinol Metab 68:53–57
Demir A, Voutilainen R, Juul A, Dunkel L, Alfthan H, Skakkebaek NE, Stenman UH (1996) Increase in first morning voided urinary luteinizing hormone levels precedes the physical onset of puberty. J Clin Endocrinol Metab 81:2963–2967
Demir A, Dunkel L, Stenman UH, Voutilainen R (1995) Age-related course of urinary gonadotropins in children. J Clin Endocrinol Metab 80:1457–1460
Stenman UH, Unkila KL, Korhonen J, Alfthan H (1997) Immunoprocedures for detecting human chorionic gonadotropin: clinical aspects and doping control. Clin Chem 43:1293–1298
Alfthan H, Haglund C, Roberts P, Stenman UH (1992) Elevation of free beta subunit of human choriogonadotropin and core beta fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease. Cancer Res 52:4628–4633
Stenman UH, Alfthan H, Hotakainen K (2004) Human chorionic gonadotropin in cancer. Clin Biochem 37:549–561
Stenman UH, Alfthan H, Ranta T, Vartiainen E, Jalkanen J, Seppala M (1987) Serum levels of human chorionic gonadotropin in nonpregnant women and men are modulated by gonadotropin-releasing hormone and sex steroids. J Clin Endocrinol Metab 64:730–736
Alfthan H, Haglund C, Dabek J, Stenman UH (1992) Concentrations of human choriogonadotropin, its beta-subunit, and the core fragment of the beta-subunit in serum and urine of men and nonpregnant women. Clin Chem 38:1981–1987
Lempiainen A, Hotakainen K, Blomqvist C, Alfthan H, Stenman UH (2007) Increased human chorionic gonadotropin due to hypogonadism after treatment of a testicular seminoma. Clin Chem 53:1560–1561
Strasburger C, Barnard G, Toldo L, Zarmi B, Zadik Z, Kowarski A, Kohen F (1989) Somatotropin as measured by a two-site time-resolved immunofluorometric assay. Clin Chem 35:913–917
Albertsson-Wikland K, Jansson C, Rosberg S, Novamo A (1993) Time-resolved immunofluorometric assay of human growth hormone. Clin Chem 39:1620–1625
Bidlingmaier M, Wu Z, Strasburger CJ (2003) Problems with GH doping in sports. J Endocrinol Invest 26:924–931
Stenman UH, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, Alfthan O (1991) A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 51:222–226
Piironen T, Lovgren J, Karp M, Eerola R, Lundwall A, Dowell B et al (1996) Immunofluorometric assay for sensitive and specific measurement of human prostatic glandular kallikrein (hK2) in serum. Clin Chem 42:1034–1041
Vaisanen V, Peltola MT, Lilja H, Nurmi M, Pettersson K (2006) Intact free prostate-specific antigen and free and total human glandular kallikrein 2. Elimination of assay interference by enzymatic digestion of antibodies to F(ab′)2 fragments. Anal Chem 78:7809–7815
Saedi MS, Hill TM, Kuus-Reichel K, Kumar A, Payne J, Mikolajczyk SD et al (1998) The precursor form of the human kallikrein 2, a kallikrein homologous to prostate-specific antigen, is present in human sera and is increased in prostate cancer and benign prostatic hyperplasia. Clin Chem 44:2115–2119
Qin Q, Christiansen M, Lovgren T, Norgaard-Pedersen B, Pettersson K (1997) Dual-label time-resolved immunofluorometric assay for simultaneous determination of pregnancy-associated plasma protein A and free beta-subunit of human chorionic gonadotropin. J Immunol Methods 205:169–175
Norgaard-Pedersen B, Alfthan H, Arends J, Hogdall CK, Larsen SO, Pettersson K et al (1994) A new simple and rapid dual assay for AFP and free beta hCG in screening for Down syndrome. Clin Genet 45:1–4
Ankelo M, Westerlund A, Blomberg K, Knip M, Ilonen J, Hinkkanen AE (2007) Time-resolved immunofluorometric dual-label assay for simultaneous detection of autoantibodies to GAD65 and IA-2 in children with type 1 diabetes. Clin Chem 53:472–479
Bünzli J-CG, Eliseeva SV (2010) Basics of lanthanide photophysics. Springer Ser Fluoresc doi: 10.1007/4243_2010_3
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Stenman, UH. (2010). Clinical Application of Time-Resolved Fluorometric Assays. In: Hänninen, P., Härmä, H. (eds) Lanthanide Luminescence. Springer Series on Fluorescence, vol 7. Springer, Berlin, Heidelberg. https://doi.org/10.1007/4243_2010_12
Download citation
DOI: https://doi.org/10.1007/4243_2010_12
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-21022-8
Online ISBN: 978-3-642-21023-5
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)